DOCSLIB.ORG

Anaesthesia Critical Care & Pain Medicine

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Anaesthesia Critical Care & Pain Medicine ANAESTHESIA CRITICAL CARE & PAIN MEDICINE Official journal of the French Society of Anaesthesia and Intensive Care (Société Francaise d'Anesthésie et de Réanimation, SFAR) AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Impact Factor p.1 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.5 ISSN: 2352-5568 DESCRIPTION . Anaesthesia, Critical Care & Pain Medicine (formerly Annales Françaises d'Anesthésie et de Réanimation) publishes in English the highest quality original material, both scientific and clinical, on all aspects of anaesthesia, critical care & pain medicine. Official journal of the French Society of Anaesthesia and Intensive Care (Société Francaise d'Anesthésie et de Réanimation, SFAR), ACCPM is signatory to the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations), and to the Committee on Publication Ethics (COPE) code of conduct for editors. ACCPM follows COPE's guidelines. ACCPM is published in electronic form only (e-only journal) and indexed in the main international databases. Issues contain (guest) Editorials, Original articles, Reviews, Special articles, Letters to the Editor, Technical notes, Short communications. Original works include clinical or laboratory investigations and clinical or equipment reports. Reviews include narrative reviews, systematic reviews and meta-analyses. All articles must: bring new, interesting, valid information - and improve clinical care or guide future research; be solely the work of the author(s) stated; not have been previously published elsewhere and not be under consideration by another journal; be written in excellent English; be in accordance with the journal's Guide for Authors. IMPACT FACTOR . 2020: 4.132 © Clarivate Analytics Journal Citation Reports 2021 AUTHOR INFORMATION PACK 2 Oct 2021 www.elsevier.com/locate/accpm 1 ABSTRACTING AND INDEXING . Current Contents - Clinical Medicine PubMed/Medline Embase Scopus Hinari Science Citation Index Expanded EDITORIAL BOARD . Editor-in-chief Jean-Yves Lefrant, Nimes University Hospital Centre Division of Anaesthesiology Intensive Care Pain Medicine and Emergencies, Nîmes, France Deputy Editor Romain Pirracchio, European Hospital Group Georges Pompidou Anaesthesia and Resuscitation Service, Paris, France Advisory Editor Dan Benhamou, Paris Sud University, Department of Anaesthesia and Intensive Care Medicine, Bicêtre Hospital, Le Kremlin-Bicêtre, France Managing Editor Rosanna Njeim, French Society of Anesthesia and Intensive Care Medecine, Paris, France Editors Bernard Allaouchiche, Civil Hospices of Lyon, Department of Anesthesia-resuscitation, Lyon, France Sylvain Ausset, Val de Grace Hospital French Military Medical Service Academy Anaesthesiology and Intensive Care, Paris, France Sophie Bastide, University Hospital Centre Nimes Laboratory of Biostatistics, Clinical Epidemiology, Public Health, Innovation and Methodology, Nimes, France Matthieu Biais, University Hospital Centre Bordeaux Department of Anaesthesiology and Critical Care Medicine, Bordeaux, France Lionel Bouvet, Lyon University Hospital, Department of Anaesthesiology and Intensive Care, Femme-Mère- Enfant Hospital, Lyon, France Olivier Brissaud, University Hospital Centre Bordeaux, Pediatric Intensive Care Unit, Bordeaux, France Sorin J. Brull, Mayo Clinic, College of Medicine and Science, Department of Anesthesiology and Perioperative Medicine, Jacksonville, United States of America Xavier Capdevila, Montpellier University Hospital Centre, Department of Anaesthesia and Intensive Care, Montpellier, France Philippe Cuvillon, Nîmes University Hospital, CHU Carémeau, Critical Care and Emergency Medicine, Pain Dept, Nîmes, France Christophe Dadure, Lapeyronie Hospital, Pediatric Anesthesia Department, Montpellier, France Jean-Stéphane David, Civil Hospices of Lyon Department of Anaesthesiology and Critical Care Medicine, Lyon, France Bin Du, Peking Union Medical College Hospital, Medical Intensive Care Unit, Beijing, China Marc-Olivier Fischer, Caen University Hospital, Anesthesiology and Critical Care Medicine Department, Caen, France Patrice Forget, University of Aberdeen, Institute of Applied Health Sciences, Department of Anaesthesia, Aberdeen, United Kingdom Tomoko Fujii, Jikei University Hospital, Intensive Care Unit, Tokyo, Japan Anne Godier, The Fondation Adolphe de Rothschild Hospital, Paris, France Dean P. Gopalan, University of KwaZulu-Natal College of Health Sciences, Durban, South Africa Sophie Hamada, Paris Sud University, Bicêtre University Hospital, Department of Anaesthesiology and Critical Care, Paris, France Ahmed Hasanin, Department of Anaesthesia and Critical Care Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt Olivier Joannes-Boyau, University Hospital Centre Bordeaux Department of Anaesthesiology and Critical Care Medicine, Bordeaux, France Sébastien Kérever, Paris University, Lariboisière University Hospital, Departments of Anaesthesiology and Critical Care, Paris, France Eric Kipnis, Lille University School of Medicine, Loos, France Kerstin Kolodzie, University of California, Department of Anesthesia and Perioperative Care, San Francisco, United States of America AUTHOR INFORMATION PACK 2 Oct 2021 www.elsevier.com/locate/accpm 2 Ruth Landau, Columbia University Vagelos College of Physicians and Surgeons, New York, United States of America Arthur Le Gall, Anaesthesia and Intensive Care Department Hospital Lariboisiere Public Assistance Hospitals Paris, Paris, France Morgan Le Guen, Hospital Foch Department of Anaesthesiology, Suresnes, France Matthieu Legrand, Hospital Saint-Louis, Paris, France Per-Arne Lönnqvist, Karolinska University Hospital, Paediatric Perioperative Medicine & Intensive Care, Stockholm, Sweden Emmanuel Lorne, CHU Amiens-Picardie, Department of Anaesthesiology and Critical Care Medicine, Amiens, France Frédéric Mercier, Paris-Saclay University, Antoine-Béclère Hospital, Department of Anaesthesia and Critical Care Medicine, Clamart, France Nicolas Mongardon, Hospital Henri Mondor, Creteil, France Armelle Nicolas-Robin, Pediatric Palliative Care Mobile Team, University Hospital Robert-Debré, Assistance Publique - Hôpitaux de Paris, Paris University, Paris, France Mark John Peters, Great Ormond Street Hospital for Children Paediatric Intensive Care Unit, London, United Kingdom Hervé Quintard, University Hospital Centre Nice Anesthesia, Resuscitation Emergency Department, Nice, France Jordi J. Rello, International University of Cataluna Faculty of Medicine and Health Sciences, Sant Cugat del Valles, Spain Philippe G. Richebé, University of Montreal Department of Anesthesiology and Pain Medicine, Montréal, Canada Jason Alexander Roberts, Royal Brisbane and Women's Hospital, Herston, Australia Antoine Roquilly, University of Nantes - Anaesthesiology and Intensive Care Unit, Nantes, France Antoine Schneider, Lausanne University Hospital Adult Intensive Care Unit, Vaud, Switzerland Francis Veyckemans, Lille University Hospital Center Department of Paediatric Resuscitation, Lille, France Paul Zetlaoui, Paris Sud University, Department of Anaesthesia and Intensive Care Medicine, Bicêtre Hospital, Le Kremlin-Bicêtre, France Guest Editors Mette Berger, Lausanne University Hospital Department of Adult Critical Care Medicine and Burns Center, Lausanne, Switzerland Jean-Michel Constantin, University of Clermont-Ferrand, Periopeartive Medicine Department, Clermont- Ferrand, France Daniel De Backer, Centre Hospitalier Interregional Edith Cavell, Bruxelles, Belgium Karen Domino, University of Washington Department of Anesthesiology and Pain Medicine, Seattle, United States of America Jeffrey Lipman, The University of Queensland, Royal Brisbane and Women's Hospital, Department of Intensive Care Medicine, Brisbane, Australia Didier Payen, University of Paris Societies and Humanities Faculty, Paris, France Rupert Pearse, Barts and The London School of Medicine and Dentistry William Harvey Research Institute, London, United Kingdom Paolo Pelosi, University of Genoa Department of Surgical and Integrated Diagnostic Sciences, Genova, Italy Jean-Charles Preiser, Erasmus Hospital, Bruxelles, Belgium Mervyn Singer, University College London Centre for Intensive Care Medicine, London, United Kingdom Jean-Louis Vincent, Erasmus Hospital Intensive Care Unit, Brussels, Belgium Social Media Editor Marc-Olivier Fischer, Caen University Hospital, Anesthesiology and Critical Care Medicine Department, Caen, France ACCPM SoMe Team Osama Abou Arab, Amiens-Picardie University Hospital, Department of Anaesthesia and Critical Care, Amiens, France Alice Blet, Lariboisière-Saint-Louis Hospitals, Department of Anaesthesiology, Critical Care and Burn Centre, DMU Parabol, AP–HP Nord, University of Paris, Paris, France Matthieu Boisson, University Hospital of Poitiers, Anaesthesiology, Critical Care and Perioperative Medicine Department,, Poitiers, France Fanny Bounes, Toulouse University Hospital, Anaesthesia Critical Care and Perioperative Medicine Department, Toulouse, France Anaïs Caillard, West Bretagne University, La Cavale Blanche University Hospital, Anaesthesiology Critical Care and Perioperative Medicine Department, Brest, France Aude Carillion, Sorbonne University, Pitié-Salpêtrière Hospitals, Anaesthesiology Critical Care and Perioperative Medicine Department, Paris, France Thomas Clavier, Rouen University Hospital, Department of Anaesthesiology,
Load more

Recommended publications
  • Speakers and Topics
    SPEAKERS AND TOPICS SALZBURG WEILL CORNELL SEMINAR ANESTHESIOLOGY AND INTENSIVE CARE Sunday, October 18 – Saturday, October 24, 2020 Schloss Arenberg, Salzburg, Austria Course Director: Hugh C. Hemmings Jr., MD, PhD, FRCA Co-Course Director: Klaus Markstaller, MD Co-Course Director: Kane O. Pryor, MD Co-Course Director: Peter Marhofer, MD SPEAKERS AND TOPICS: Meghann M. Fitzgerald, MD Assistant Professor of Clinical Anesthesiology Weill Cornell Medical College Assistant Attending Anesthesiologist NewYork-Presbyterian Hospital Weill Cornell Medicine Anesthesiology New York, NY USA • Robotic Cardiac Surgery • Blood Management in Cardiac Surgery • TAAA Repair Lukas Kirchmair, MD, PD, DESA, EDRA Department of Anesthesiology and Intensive Care District Hospital Schwaz Schwaz Austria • Polytrauma Management Rudolf Likar, MD, MSc Professor Head, Department of Anesthesiology and Intensive Care General Hospital Klagenfurt Klagenfurt am Woerthersee Austria • Invasive Methods in Cancer Pain • Invasive Methods in Low Back Pain © Open Medical Institute 2020 SPEAKERS AND TOPICS Peter Marhofer, MD Professor of Anesthesia and Intensive Care Medicine Department of Anesthesia and Intensive Care Medicine Medical University of Vienna Vienna Austria • Principles of Regional Anaesthesia I • Principles of Regional Anaesthesia II • Ultrasound in Anaesthesia and Intensive Care Medicine I • Ultrasound in Anaesthesia and Intensive Care Medicine II Rohan Panchamia, MD Assistant Professor of Clinical Anesthesiology Weill Cornell Medical College Assistant Attending
    [Show full text]
  • COVID-19 Pneumonia: Different Respiratory Treatment for Different Phenotypes? L
    Intensive Care Medicine EDITORIAL Un-edited accepted proof COVID-19 pneumonia: different respiratory treatment for different phenotypes? L. Gattinoni1, D. Chiumello2, P. Caironi3, M. Busana1, F. Romitti1, L. Brazzi4, L. Camporota5 Affiliations: 1Department of Anesthesiology and Intensive Care, Medical University of GöttinGen 4Department of Anesthesia, Intensive Care and Emergency - 'Città della Salute e della Scienza’ Hospital - Turin 5Department of Adult Critical Care, Guy’s and St Thomas’ NHS Foundation Trust, Health Centre for Human and Applied Physiological Sciences - London Corresponding author: Luciano Gattinoni Department of Anesthesiology and Intensive Care, Medical University of Göttingen, Robert-Koch Straße 40, 37075, Göttingen, Germany Conflict of interests: The authors have no conflict of interest to disclose NOTE: This article is the pre-proof author’s accepted version. The final edited version will appear soon on the website of the journal Intensive Care Medicine with the following DOI number: DOI 10.1007/s00134-020-06033-2 1 Gattinoni L. et al. COVID-19 pneumonia: different respiratory treatment for different phenotypes? (2020) Intensive Care Medicine; DOI: 10.1007/s00134-020-06033-2 Intensive Care Medicine EDITORIAL Un-edited accepted proof The Surviving Sepsis CampaiGn panel (ahead of print, DOI: 10.1007/s00134-020-06022-5) recently recommended that “mechanically ventilated patients with COVID-19 should be managed similarly to other patients with acute respiratory failure in the ICU.” Yet, COVID-19 pneumonia [1], despite falling in most of the circumstances under the Berlin definition of ARDS [2], is a specific disease, whose distinctive features are severe hypoxemia often associated with near normal respiratory system compliance (more than 50% of the 150 patients measured by the authors and further confirmed by several colleagues in Northern Italy).
    [Show full text]
  • MLOZ Headquarters in Brussels ABSTRACT of the PROJECT
    MLOZ Headquarters in Brussels ABSTRACT OF THE PROJECT 1 About MLOZ : The independent grouping of independent healthcare mutual societies MLOZ, recently made a major change to their office premises. They are now located on the Route de Lennik in Anderlecht, in the vicinity of the Erasmus hospital. To pilot this major evolution, MLOZ (Mutualités Libres / Onafhankelijk Ziekenfonds ) called on the services of real estate advisor Colliers International 2 At the end of the construction works, MLOZ asked also Colliers to take TECHNICAL PROJECT FILE charge of the interior design and fit- out of the new building but mandated also them to re-fit of the Address of the projet building opposite in a similar style, Lenniksebaan 788A its tenant having now been merged 1070 Brussels. into MLOZ. This work is ongoing, and includes the displacement of the Customer personnel as necessary in phases. Mut ualités Libres/Onafhankelijke Ziekenfondsen The two floors of the new building are characterised by a central ‘street’ Type of projet which acts as the main New construction communication channel. Four ‘wings’ NWOW project run off from this street, with open working areas, and each has a Final assignment of the building specific colour treatment. The colour Offices scheme is otherwise largely white, which gives a further feeling of Surface: NEW MLOZ openness to the entire complex. 8.900 sqm HEADQUARTERS IN The personnel now work according BRUSSELS to the ‘flex desk’ principle with ‘clean The process started by a ‘stay or desk’ policy. Meeting rooms of Establishment of the concept : leave’ analysis. The result was that different sizes enable private ABW (Activity Based Working) either they had to select another conversations, along with small building than their current location in ‘bubbles’ for one-to-one discussions, Brussels, located close to and coffee corners for informal Montgomery, or construct a new meetings Calendar building.
    [Show full text]
  • Intensive Care Medicine in 10 Years
    BOOKS,FILMS,TAPES &SOFTWARE are difficult to read, the editing is inconsis- tory for critical care medicine. The book is initiate a planning process for leaders who tent, and the content that was omitted indi- divided into sections entitled “Setting the recognize the imperative for change and ad- cates that “efforts to bring this work from Stage,” “Diagnostic, Therapeutic, and In- aptation in critical care. Accordingly, I rec- conception to fruition in less than one year” formation Technologies 10 Years From ommend this book to individuals and groups (as stated in the book’s acknowledgments Now,” “How Might Critical Care Medicine engaged in all aspects of critical care man- section) prevented this book from being a Be Organized and Regulated?” “Training,” agement, now and in the future. “gold standard” text. and “The Critical Care Agenda.” Each sec- J Christopher Farmer MD tion consists of a series of essays/chapters Marie E Steiner MD MSc Department of Medicine that discuss various aspects of the topic, and Department of Pediatrics Mayo Clinic all the sections have solid scientific support Divisions of Pulmonary/ Rochester, Minnesota and bibliographies. The individual topics Critical Care and Hematology/ span the entire range of critical-care clinical Oncology/Blood and Marrow The author reports no conflict of interest related practice, administration, quality and safety, Transplantation to the content of this book review. and so forth. The contributors are acknowl- University Children’s Hospital, Fairview edged senior clinical and scientific leaders University of Minnesota Mechanical Ventilation: Physiological in critical care medicine from around the Minneapolis, Minnesota and Clinical Applications, 4th edition.
    [Show full text]
  • Intravenous Immunoglobulin Fails to Improve ARDS in Patients
    Prohaska et al. Journal of Intensive Care (2018) 6:11 DOI 10.1186/s40560-018-0278-8 RESEARCH Open Access Intravenous immunoglobulin fails to improve ARDS in patients undergoing ECMO therapy Stefanie Prohaska1, Andrea Schirner1, Albina Bashota1, Andreas Körner1, Gunnar Blumenstock2 and Helene A. Haeberle1* Abstract Background: Acute respiratory distress syndrome (ARDS) is associated with high mortality rates. ARDS patients suffer from severe hypoxemia, and extracorporeal membrane oxygenation (ECMO) therapy may be necessary to ensure oxygenation. ARDS has various etiologies, including trauma, ischemia-reperfusion injury or infections of various origins, and the associated immunological responses may vary. To support the immunological response in this patient collective, we used intravenous IgM immunoglobulin therapy to enhance the likelihood of pulmonary recovery. Methods: ARDS patients admitted to the intensive care unit (ICU) who were placed on ECMO and treated with (IVIG group; n = 29) or without (control group; n = 28) intravenous IgM-enriched immunoglobulins for 3 days in the initial stages of ARDS were analyzed retrospectively. Results: The baseline characteristics did not differ between the groups, although the IVIG group showed a significantly reduced oxygenation index compared to the control group. We found no differences in the length of ICU stay or ventilation parameters. We did not find a significant difference between the groups for the extent of inflammation or for overall survival. Conclusion: We conclude that administration
    [Show full text]
  • Characteristics and Risk Factors for Intensive Care Unit Cardiac Arrest in Critically Ill Patients with COVID-19—A Retrospective Study
    Journal of Clinical Medicine Article Characteristics and Risk Factors for Intensive Care Unit Cardiac Arrest in Critically Ill Patients with COVID-19—A Retrospective Study Kevin Roedl 1,* , Gerold Söffker 1, Dominic Wichmann 1 , Olaf Boenisch 1, Geraldine de Heer 1 , Christoph Burdelski 1, Daniel Frings 1, Barbara Sensen 1, Axel Nierhaus 1 , Dirk Westermann 2, Stefan Kluge 1 and Dominik Jarczak 1 1 Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany; [email protected] (G.S.); [email protected] (D.W.); [email protected] (O.B.); [email protected] (G.d.H.); [email protected] (C.B.); [email protected] (D.F.); [email protected] (B.S.); [email protected] (A.N.); [email protected] (S.K.); [email protected] (D.J.) 2 Department of Interventional and General Cardiology, University Heart Centre Hamburg, 20246 Hamburg, Germany; [email protected] * Correspondence: [email protected]; Tel.: +49-40-7410-57020 Abstract: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causing the coron- avirus disease 2019 (COVID-19) led to an ongoing pandemic with a surge of critically ill patients. Very little is known about the occurrence and characteristic of cardiac arrest in critically ill patients Citation: Roedl, K.; Söffker, G.; with COVID-19 treated at the intensive care unit (ICU). The aim was to investigate the incidence Wichmann, D.; Boenisch, O.; de Heer, and outcome of intensive care unit cardiac arrest (ICU-CA) in critically ill patients with COVID-19. G.; Burdelski, C.; Frings, D.; Sensen, This was a retrospective analysis of prospectively recorded data of all consecutive adult patients B.; Nierhaus, A.; Westermann, D.; with COVID-19 admitted (27 February 2020–14 January 2021) at the University Medical Centre et al.
    [Show full text]
  • Rapid Evidence Review
    Rapid Evidence Review Clinical evidence for the use of intravenous immunoglobulin in the treatment of COVID- 19 Version 2, 14th May 2020 1 Prepared by the COVID-19 Evidence Review Group with clinical contribution from Dr. Niall Conlon, Consultant Immunologist, St. James Hospital, Dr. Mary Keogan, Clinical Lead National Clinical Programme for Pathology & Consultant Immunologist, Beaumont Hospital. Key changes between version 1 and version 2 (14th May 2020) A number of case reports describing the use of IVIG are included in this version and 2 additional studies which focused specifically on the use of IVIG in patients with COVID-19 – one case series and one retrospective cohort study (available as a pre-print). A number of guidelines have included a reference to IVIG, but the general consensus is not to use IVIG. The recent reports of Kawasaki Disease in children with COVID-19 highlight the role of IVIG and aspirin to treat this condition and supporting evidence of its benefit are available from 2 case reports and one case series. The COVID-19 Evidence Review Group for Medicines was established to support the HSE in managing the significant amount of information on treatments for COVID-19. This COVID-19 Evidence Review Group is comprised of evidence synthesis practitioners from across the National Centre for Pharmacoeconomics (NCPE), Medicines Management Programme (MMP) and the National Medicines Information Centre (NMIC). The group respond to queries raised via the Office of the CCO, National Clinical Programmes and the Department of Health and respond in a timely way with the evidence review supporting the query.
    [Show full text]
  • Surviving Sepsis Campaign Guidelines for COVID-19
    DISCLAIMER. The information contained herein is subject to change. The final version of the article will be published as soon as approved on ccmjournal.org. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) Waleed Alhazzani1,2, Morten Hylander Møller3,4, Yaseen M. Arabi5, Mark Loeb1,2, Michelle Ng Gong6, Eddy Fan7, Simon Oczkowski1,2, Mitchell M. Levy8,9, Lennie Derde10,11, Amy Dzierba12, Bin Du13, Michael Aboodi6, Hannah Wunsch14,15, Maurizio Cecconi16,17, Younsuck Koh18, Daniel S. Chertow19, Kathryn Maitland20, Fayez Alshamsi21, Emilie Belley-Cote1,22, Massimiliano Greco16,17, Matthew Laundy23, Jill S. Morgan24, Jozef Kesecioglu10, Allison McGeer25, Leonard Mermel8, Manoj J. Mammen26, Paul E. Alexander2,27, Amy Arrington28, John Centofanti29, Giuseppe Citerio30,31, Bandar Baw1,32, Ziad A. Memish33, Naomi Hammond34,35, Frederick G. Hayden36, Laura Evans37, Andrew Rhodes38 Affiliations 1 Department of Medicine, McMaster University, Hamilton, Canada 2 Department of Health Research Methods, Evidence, and Impact, McMaster University, Canada 3 Copenhagen University Hospital Rigshospitalet, Department of Intensive Care, Copenhagen, Denmark 4 Scandinavian Society of Anaesthesiology and Intensive Care Medicine (SSAI) 5 Intensive Care Department, Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia 6 Department of Medicine, Montefiore Healthcare
    [Show full text]
  • Annual Security Report
    ANNUAL SECURITY REPO RT ANNUAL FIRE SAFETY R EPORT "YOUR RIGHT TO KNOW" http://www.jmu.edu/pubsafety/righttoknow.shtml SAFETY AT JAMES MADISON UNIVERSITY’S SEMESTER IN ANTWERP In Compliance with the federal Jeanne Clery Disclosure of Campus Security Policy and Campus Crime Statistics Act of 1998 (formerly the Crime Awareness and Campus Security Act of 1990) October 1, 2011 Annual Security Report Safety on the JMU Antwerp campus, Antwerp Hall/Montpelier Hall, is a natural source of concern for parents, students and employees. Education - the business of James Madison University – can only take place in an environment in which each student employee and visitor feels safe and secure. JMU recognizes this and employs a number of security measures to protect the members of its community. Crime prevention remains a high priority among residents. JMU does its part to help ensure the safety of its students, employees and visitors. The Program Director, the Faculty Member in Residence (FMIR), the Program Assistant (PA), Resident Manager (RM) and the students themselves all share in the responsibility of making the Antwerp campus, specifically our residential hostel, Montpelier Hall, a safe place to study, work and live. Antwerp Population The inner city of Antwerp has approximately half a million inhabitants. About a million people live in greater Antwerp. The Language The province of Antwerp is part of Flanders, and the official language of Flanders is Dutch. Since residents of Flanders speak Dutch with a different accent than residents of the Netherlands, they call their dialect of the Dutch language ―Flemish.‖ The Flemish and the Dutch have no trouble understanding each other.
    [Show full text]
  • Best-Practice Igm- and Iga-Enriched Immunoglobulin Use in Patients with Sepsis
    Nierhaus et al. Ann. Intensive Care (2020) 10:132 https://doi.org/10.1186/s13613-020-00740-1 REVIEW Open Access Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis Axel Nierhaus1,2* , Giorgio Berlot3, Detlef Kindgen‑Milles4, Eckhard Müller5 and Massimo Girardis6 Abstract Background: Sepsis is a life‑threatening organ dysfunction caused by a dysregulated host response to infection. Despite treatment being in line with current guidelines, mortality remains high in those with septic shock. Intrave‑ nous immunoglobulins represent a promising therapy to modulate both the pro‑ and anti‑infammatory processes and can contribute to the elimination of pathogens. In this context, there is evidence of the benefts of immuno‑ globulin M (IgM)‑ and immunoglobulin A (IgA)‑enriched immunoglobulin therapy for sepsis. This manuscript aims to summarize current relevant data to provide expert opinions on best practice for the use of an IgM‑ and IgA‑enriched immunoglobulin (Pentaglobin) in adult patients with sepsis. Main text: Sepsis patients with hyperinfammation and patients with immunosuppression may beneft most from treatment with IgM‑ and IgA‑enriched immunoglobulin (Pentaglobin). Patients with hyperinfammation present with phenotypes that manifest throughout the body, whilst the clinical characteristics of immunosuppression are less clear. Potential biomarkers for hyperinfammation include elevated procalcitonin, interleukin‑6, endotoxin activity and C‑reactive protein, although thresholds for these are not well‑defned. Convenient biomarkers for identifying patients in a stage of immune‑paralysis are still matter of debate, though human leukocyte antigen–antigen D related expression on monocytes, lymphocyte count and viral reactivation have been proposed. The timing of treatment is potentially more critical for treatment efcacy in patients with hyperinfammation compared with patients who are in an immunosuppressed stage.
    [Show full text]
  • Recommendations for End-Of-Life Care in the Intensive Care Unit: a Consensus Statement by the American College of Critical Care Medicine
    Special Articles Recommendations for end-of-life care in the intensive care unit: A consensus statement by the American College of Critical Care Medicine Robert D. Truog, MD, MA; Margaret L. Campbell, PhD, RN, FAAN; J. Randall Curtis, MD, MPH; Curtis E. Haas, PharmD, FCCP; John M. Luce, MD; Gordon D. Rubenfeld, MD, MSc; Cynda Hylton Rushton, PhD, RN, FAAN; David C. Kaufman, MD Background: These recommendations have been developed to to die, and between consequences that are intended vs. those that improve the care of intensive care unit (ICU) patients during the are merely foreseen (the doctrine of double effect). Improved dying process. The recommendations build on those published in communication with the family has been shown to improve pa- 2003 and highlight recent developments in the field from a U.S. tient care and family outcomes. Other knowledge unique to end- perspective. They do not use an evidence grading system because of-life care includes principles for notifying families of a patient’s most of the recommendations are based on ethical and legal death and compassionate approaches to discussing options for principles that are not derived from empirically based evidence. organ donation. End-of-life care continues even after the death of Principal Findings: Family-centered care, which emphasizes the patient, and ICUs should consider developing comprehensive the importance of the social structure within which patients are bereavement programs to support both families and the needs of embedded, has emerged as a comprehensive ideal for managing the clinical staff. Finally, a comprehensive agenda for improving end-of-life care in the ICU.
    [Show full text]
  • Press Release
    UCB S.A. 60 Allée de la Recherche, B-1070 Brussels (Belgium) Press Release Brussels, 3 December 2004 H.R.H. PRINCE PHILIPPE OF BELGIUM VISITS THE UCB SITE IN BRAINE- L’ALLEUD TOGETHER WITH THE WALLOON AUTHORITIES During his visit at the UCB site in Braine-l’Alleud on Friday 3 December 2004, H.R.H. Prince Philippe of Belgium presided over a round-table discussion on the topic of "pharmaceutical research: safeguarding the future”. The participants were: Jean-Claude Van Cauwenberghe, Minister-President of the Walloon Region, Jean-Claude Marcourt, Walloon Minister for the Economy and the Employment, Marie-Dominique Simonet, Walloon Minister for Scientific Research and New Technology, Jean-Louis Vanherweghem, President of the Board of ULB, Marcel Crochet, former Rector of UCL, Kurt Vandenberghe, European Commission, Thierry Appelboom, Professor, rheumatologist at Erasmus Hospital, Jean Stephenne, President and General Manager of GSK Biologicals, Roch Doliveux, Director-General of UCB Pharma, and Georges Jacobs, Chairman of the Executive Committee of UCB. The discussion brought to the fore the conditions needed to guarantee the future of the pharmaceutical industry in Belgium and in particular Wallonia. Wallonia must develop a highly qualified workforce in this sector, which provides considerable added value as a clean, environmentally friendly industry that uses few raw materials and is likely to generate exports. At the round-table discussion, the leaders of industry stressed the need for a climate that promotes a spirit of entrepreneurship and innovation and that meets training requirements so as to attract the sectors of research and production to the Walloon region.
    [Show full text]